Skip to content
Search
Search
Contact Us
Careers
Contact Us
Careers
About Us
Leadership
Executive Leadership
Board of Directors
Mission
Culture
Contact
Our Science
Pipeline
Govorestat
AT-001
Presentations and Publications
Patients & Caregivers
Patient Resources
Investors & Media
Stock Info
Financial Info
Corporate Governance
Events
Press Releases
Investor Resources
Investor FAQs
Email Alerts
Investor Contacts
X
AT-007 receives FDA Pediatric Rare Disease Designation
AT-007 receives
FDA
Pediatric Rare Disease Designation for Galactosemia